Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Routine versus selective protamine administration after TAVI
2023-504205-36-00Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised trial of protamine in aortic stenosis (AS) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Composite of cardiovascular mortality or clinically relevant bleeding. Started Jun 2023; status: completed.
02
Drugs
protamine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2023-504205-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504205-36-00.